Double Digit NASDAQ Stock Winners: SONN, SNOA, DLO
8:03 am Friday, August 20th, 2021
Following are major stock gainers on Nasdaq in Thursday’s trading session:
Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) was the active stock gainer on Thursday and soared 64% to $1.22 after the company announced the pricing of an underwritten public offering of 35,294,117 shares of common stock or common stock equivalents (which includes pre-funded warrants to purchase shares of common stock in lieu of shares of common stock) and investor warrants to purchase up to an aggregate of 35,294,117 shares of common stock.
Each share of common stock (or pre-funded warrant in lieu thereof) is being sold together with one investor warrant to purchase one share of common stock at a combined offering price of $0.85, for total gross proceeds of approximately $30.0 million, before underwriting discounts and commissions and offering expenses payable by Sonnet. The investor warrants have an exercise price of $0.85 per share. The offering is expected to close on or about August 24, 2021, subject to the satisfaction or waiver of customary closing conditions.
Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) was another notable winner as the stock went up 50% to end the session at $8.15 after the company announced it launched two new dental products.
Sonoma Pharmaceuticals launched OroGenix Oral Hygiene Rinse, which was developed with Gabriel Science and is the company’s second dental product in the U.S. OroGenix Oral Hygiene Rinse uses Sonoma’s patented Microcyn technology to cleanse teeth, gums, and mouth. Sonoma and Medical Systems Solutions also launched Microdacyn Oral Care for both professional and consumer use in Switzerland. The product aims to combat oral and pharyngeal infections and inflammation, and reduce pain and coughing.
DLocal Limited (NASDAQ:DLO) surged 27% to $62.43. Management reported strong second-quarter earnings after the market closed yesterday, and shares of DLocal Limited (NASDAQ:DLO), an online-payments services provider that focuses on emerging markets, are soaring today. The Q2 2021 earnings report isn’t the only catalyst for the stock’s movement today, though; the rise is also a reflection of some positive attention from Wall Street.
DLocal smashed analysts’ Q2 2021 revenue estimates of $40.5 million and reported $59 million on the top line. The company surpassed analysts’ earnings-per-share expectations of $0.05 as well, though not as dramatically, posting diluted EPS of $0.057. Investors today, however, are likely impressed with much more than just the sales and earnings figures.
